IABP systems are typically inserted within the multidisciplinary environment that is the cardiac catheterization laboratory. The specific role of the physiologist during IABP insertion is to ensure ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced it designated a recall of intra-aortic balloon pumps due to problems related to fluid leak as ...
Getinge is recalling 4,338 intra-aortic balloon pumps after discovering fluid leaks that can lead to unexpected shutdowns or the inability to initiate therapy, the FDA said Dec. 16. The agency has ...
Please provide your email address to receive an email when new articles are posted on . Arrow International announced it is recalling its intra-aortic balloon pumps after receiving complaints about ...
Augusta, Ga. – The most frequently used mechanical circulatory assist device in the world may have untapped potential, physicians say. One of many uses for the intra-aortic balloon pump is helping ...
DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...
The Cardiosave Hybrid and Cardiosave Rescue intra-aortic balloon pumps (IABPs) have been hit with another recall by the manufacturer (Getinge/Datascope), this time due to damage to the balloon ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
WAYNE, N.J., Maquet Getinge Group announced today the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-aortic balloon pumps ...
In a flurry of Aug. 31 notices from the FDA, the number of Class I recalls plaguing Getinge’s Cardiosave intra-aortic balloon pumps this year has doubled. The notices detailed four more recalls of the ...
Two deaths, one serious injury and more than 60 medical device reports have been linked to Maquet/Datascope’s intra-aortic balloon pumps in the past year, the FDA warned healthcare providers in a Nov.
The rapid increase in the number of percutaneous coronary interventions being performed has led to a corresponding rise in the complexity of lesions attempted and the extent of patient comorbidities ...